{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:19:09Z","timestamp":1778901549947,"version":"3.51.4"},"reference-count":19,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,6,3]]},"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>We encountered a man in his 60s presenting with worsening macroglossia. The patient underwent extensive otolaryngology evaluation and was diagnosed with primary (AL) amyloidosis on tongue biopsy with Congo red stain. The patient then underwent a bone marrow biopsy and was also found to have concurrent multiple myeloma. He started induction therapy with daratumumab and CyBorD (cyclophosphamide, bortezomib, dexamethasone). Cardiac MRI revealed extensive cardiac amyloidosis and the patient was deemed high risk for autologous stem cell transplant (auto-HCT). Unfortunately, the patient underwent hospitalisation for heart failure exacerbation requiring extensive medical management and passed away as a result of this pathology. AL amyloidosis is a rare disease to begin with and macroglossia as the only presenting sign is notable. This case emphasises the importance of considering AL amyloidosis in patients presenting with similar complaints as macroglossia can be attributed to other less serious aetiologies.<\/jats:p>","DOI":"10.1136\/bcr-2022-249737","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T11:46:14Z","timestamp":1657539974000},"page":"e249737","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Macroglossia as the initial presentation of AL amyloidosis: review and updates in treatment"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-6187","authenticated-orcid":false,"given":"Adriani Samuel","family":"Cherico","sequence":"first","affiliation":[{"name":"Internal Medicine, Allegheny General Hospital - Western Pennsylvania Hospital Medical Education Consortium, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Rizvi","sequence":"additional","affiliation":[{"name":"Internal Medicine, Allegheny General Hospital - Western Pennsylvania Hospital Medical Education Consortium, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thejus","family":"Jayakrishnan","sequence":"additional","affiliation":[{"name":"Internal Medicine, Allegheny General Hospital - Western Pennsylvania Hospital Medical Education Consortium, Pittsburgh, Pennsylvania, USA"},{"name":"Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prerna","family":"Mewawalla","sequence":"additional","affiliation":[{"name":"Division of Hematology and Cellular Therapy, AHN Cancer Center, Allegheny Health Network, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"2025082708564390000_15.7.e249737.1","unstructured":"Jameson JL , Fauci AS , Kasper DL . Harrison\u2019s Principles of Internal Medicine. 20th edn. New York: The McGraw-Hill Companies, Inc, 2018: 803\u20137."},{"key":"2025082708564390000_15.7.e249737.2","first-page":"470","article-title":"Immunoglobulin light-chain amyloidosis: clinical presentations and diagnostic approach","volume":"10","author":"Hwa","year":"2019","journal-title":"J Adv Pract Oncol"},{"key":"2025082708564390000_15.7.e249737.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0080-9"},{"key":"2025082708564390000_15.7.e249737.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004460"},{"key":"2025082708564390000_15.7.e249737.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2788"},{"key":"2025082708564390000_15.7.e249737.6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016402"},{"key":"2025082708564390000_15.7.e249737.7","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2018.022"},{"key":"2025082708564390000_15.7.e249737.8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000506617","article-title":"When to suspect a diagnosis of amyloidosis","volume":"143","author":"Vaxman","year":"2020","journal-title":"Acta Haematol"},{"key":"2025082708564390000_15.7.e249737.9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5348\/ijcri-201558-CR-10519","article-title":"Macroglossia and periorbital ecchymoses in a patient with systemic amyloidosis: a case report","volume":"6","author":"Costa","year":"2015","journal-title":"Int J Case Rep Imag"},{"key":"2025082708564390000_15.7.e249737.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6966.1386"},{"key":"2025082708564390000_15.7.e249737.11","first-page":"3009","article-title":"Amyloid deposition in the tongue: clinical and histopathological profile","volume":"30","author":"Angiero","year":"2010","journal-title":"Anticancer Res"},{"key":"2025082708564390000_15.7.e249737.12","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/91.2.141"},{"key":"2025082708564390000_15.7.e249737.13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00508-020-01781-z","article-title":"Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement","volume":"132","author":"Bonderman","year":"2020","journal-title":"Wien Klin Wochenschr"},{"key":"2025082708564390000_15.7.e249737.14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/CMAR.S287922","article-title":"Effects of amyloid light-chain amyloidosis on clinical characteristics and prognosis in multiple myeloma: a single-center retrospective study","volume":"13","author":"Xu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"2025082708564390000_15.7.e249737.15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11899-021-00626-4","article-title":"Amyloidosis with cardiac involvement: identification, characterization, and management","volume":"16","author":"Jamal","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"2025082708564390000_15.7.e249737.16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood.2019004436","article-title":"Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study","volume":"135","author":"Sanchorawala","year":"2020","journal-title":"Blood"},{"key":"2025082708564390000_15.7.e249737.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134307"},{"key":"2025082708564390000_15.7.e249737.18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.100"},{"key":"2025082708564390000_15.7.e249737.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7614"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-249737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:56:49Z","timestamp":1756310209000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-249737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,11]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/bcr-2022-249737"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-249737","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}